Clin2
NCT06951984Possibly a fitRecruiting

HED PET/CT scan for people with tumors

Sympathetic Nervous System DiseasesSympathetic Nervous Structure InjurySympathetic Nerve Injury

Part of Brain & nervous system clinical trials.

This trial uses a special PET/CT scan called HED to look at the sympathetic nervous system in people with suspected or known tumors. It may help doctors better understand how tumors affect this part of the body.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a suspected or confirmed tumor (based on MRI, CT, blood tests, or biopsy)
  • You are scheduled for a HED PET/CT scan
  • You can give informed consent (or have a parent or legal representative do so)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06909604Recruiting
PET scan for HER2 breast cancer during treatment

This trial tests a new imaging test (a special PET scan) that can see HER2 proteins in breast cancer tumors. It is for people who are already getting treatment before surgery to see if the scan helps doctors understand how well the therapy is working.

Beijing
NCT04547309Recruiting
Imaging test using a HER2-targeting tracer

This trial studies an imaging tracer that targets HER2, a protein that can be found in certain cancers. It may help doctors see where HER2-positive tumors are in the body using scans.

Beijing, Beijing Municipality
NCT07487883Recruiting
PET scan for lung cancer using a special tracer

This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.

Beijing, Beijing Municipality
NCT07590336Not yet recruiting· Phase 1/Phase 2
Advanced imaging scan for liver cancer detection

This study tests a new type of imaging scan (called 68Ga-NYM207 PET/CT) that may help doctors better find and understand liver cancer. You would receive the scan once to see if it helps doctors plan your treatment or monitor your cancer.

Beijing
NCT06548529Recruiting
HER2 PET/CT scan to predict treatment response in bladder cancer

This trial uses a special PET/CT scan to see if your bladder cancer has HER2 proteins, which can help predict how well you will respond to a targeted antibody-drug conjugate treatment. It is for people with advanced bladder cancer who have already tried certain standard therapies.

Beijing
NCT07144748Recruiting
New PET/CT scan for finding cancer

This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.

Beijing

Hear when a new Sympathetic Nervous System Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.